Page 20 - U.S. Pharmaceuticals & Biotech Stocks - Top Gainers Today

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
RAIN Rain Oncology	US$1.21	0%	-87.9%	US$44.0m	US$1.30	PB0.7x	E23.3%	n/a
BCRX BioCryst Pharmaceuticals	US$7.50	0%	22.0%	US$1.6b	US$14.64	PS3.8x	E72.8%	n/a
FATE Fate Therapeutics	US$3.17	0%	19.6%	US$361.0m	US$6.31	PS26.8x	E-9.2%	n/a
ARAV Aravive	US$0.04	0%	-97.6%	US$2.9m	n/a	PB1.7x	n/a	n/a
ENLV Enlivex Therapeutics	US$1.14	0%	-36.7%	US$24.4m	US$9.50	PB0.9x	E-27.0%	n/a
CVAC CureVac	US$2.87	0%	-47.8%	US$643.8m	US$7.31	PS9.2x	E31.9%	n/a
PRLD Prelude Therapeutics	US$1.05	0%	-67.4%	US$57.8m	US$5.40	PS19.3x	E-7.1%	n/a
AFMD Affimed	US$2.84	0%	-36.9%	US$46.6m	US$28.15	PS7.8x	E-14.5%	n/a
HBIO Harvard Bioscience	US$2.20	0%	-50.0%	US$95.9m	US$6.25	PB1.5x	E89.4%	n/a
SCYX SCYNEXIS	US$1.37	0%	-20.3%	US$52.0m	US$6.67	PS6.1x	E48.7%	n/a
GNLX Genelux	US$2.69	0%	-79.8%	US$91.7m	US$18.40	PS11467.8x	E12.0%	n/a
ORTX Orchard Therapeutics	US$16.70	0%	188.9%	US$380.1m	US$16.00	PS17.4x	E12.5%	n/a
THRX Theseus Pharmaceuticals	US$4.06	0%	-63.4%	US$180.7m	n/a	PB0.8x	E-6.3%	n/a
KNTE Kinnate Biopharma	US$2.65	0%	-56.8%	US$125.1m	US$2.30	PB0.8x	E14.6%	n/a
LABP Landos Biopharma	US$22.93	0%	693.4%	US$71.7m	US$20.42	PB3.1x	E-37.1%	n/a
LUMO Lumos Pharma	US$4.30	0%	41.4%	US$37.2m	US$4.25	PS16.9x	E-11.6%	n/a
ARMP Armata Pharmaceuticals	US$2.30	0%	-3.0%	US$83.2m	US$7.00	PS15.2x	E-52.2%	n/a
ATNM Actinium Pharmaceuticals	US$1.44	0%	-71.4%	US$44.9m	US$5.00	PS554.6x	E-0.6%	n/a
AKBA Akebia Therapeutics	US$2.06	0%	92.5%	US$449.5m	US$5.50	PS2.6x	E71.4%	n/a
BCLI Brainstorm Cell Therapeutics	US$1.74	0%	-55.4%	US$9.9m	US$23.45	PE-0.7x	E15.9%	n/a
DCPH Deciphera Pharmaceuticals	US$25.59	0%	76.5%	US$2.2b	US$26.85	PS12.7x	E50.6%	n/a
NBSE NeuBase Therapeutics	US$0.38	0%	-90.2%	US$1.4m	n/a	PB0.1x	n/a	n/a
ORMP Oramed Pharmaceuticals	US$2.37	0%	11.3%	US$95.5m	US$3.25	PE21.4x	E-163.0%	n/a
LVTX LAVA Therapeutics	US$1.60	0%	6.7%	US$42.1m	US$7.41	PS5.7x	E-21.4%	n/a